| Literature DB >> 19075017 |
Young-Il Jeong1, Sang Woo Kim, In Duk Jung, Jun Sik Lee, Jeong Hyun Chang, Chang-Min Lee, Sung Hak Chun, Man-Soo Yoon, Geun Tae Kim, Seok Woo Ryu, Jong-Suk Kim, Yong Kyoo Shin, Won Suk Lee, Hwa Kyoung Shin, Jae-Dong Lee, Yeong-Min Park.
Abstract
Indoleamine 2,3-dioxygenase (IDO) catalyzes the initial and rate-limiting step in the degradation of tryptophan and is strongly induced in interferon-gamma (IFNgamma)-stimulated dendritic cells (DCs). IDO has recently been established as a key enzyme in T-cell suppression-mediated immune tolerance to tumors. STAT1 phosphorylation appears to play an important role in the control of IDO expression by IFNgamma, but the precise regulatory mechanism remains obscure. Here we present a novel mechanism of IFNgamma-induced IDO expression in bone marrow-derived dendritic cells. In addition, we demonstrate that curcumin, an active component of turmeric, significantly inhibited the induction of IDO expression and activity by IFNgamma. We found that curcumin suppressed STAT1 activation by directly inhibiting Janus-activated kinase 1/2 and protein kinase Cdelta phosphorylation in bone marrow-derived DCs, suppressing the subsequent translocation and binding of STAT1 to the GAS element of the IRF-1 promoter. Coincident with these inhibitory effects on IFNgamma-induced IDO expression, curcumin reversed IDO-mediated suppression of T-cell responses. Our results, thus, suggest that down-regulation of IDO in DCs is an important immunomodulatory property of curcumin that may be exploited therapeutically in the control of cancers.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19075017 DOI: 10.1074/jbc.M807328200
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157